FTC Supports Plan to Crack Down on Petitions to Delay Generics

Drug Industry Daily
A A
The Federal Trade Commission endorsed FDA draft guidance that aims to deter drugmakers from gaming the citizen petition process to delay generics.

To View This Article:

Login

Subscribe To Drug Industry Daily